First gene therapy approval for bladder cancer ... is what happened
1 Views
administrator
07/08/23
On 16th December 2022, US-FDA approved Adstiladrin first gene therapy for the treatment of high-risk Non-Muscle-Invasive Bladder Cancer. Subscribe channel for recent updates. #fdaapproved #cancer #bladdercancer #oncology #oncologyurology #doodle #doodleart #medicalupdate #educationupdate #cancerupdate #doodlevideo #genetherapy #fdaapproval #fda #lifesaving #cellandgenetherapy
-
Category
Show more
Facebook Comments
No comments found